WEST PALM BEACH, FL--(Marketwired - Sep 19, 2013) - BioNitrogen Corporation (
"This patent is an important milestone in BioNitrogen's strategy and confirms the uniqueness of our technology and process." said Bryan Kornegay, President and CFO of BioNitrogen. "This patent is a key intellectual property asset and significantly enhances our competitive position in the marketplace."
About BioNitrogen Corporation
BioNitrogen Corp. (
Safe Harbor Statement
The forward-looking statements contained in this document involve risks and uncertainties that may affect the Company's operations, markets, products, services, prices and other factors as discussed in filings with the Securities and Exchange Commission. These risks and uncertainties include, but are not limited to, economic, competitive, legal, governmental and technological factors. Accordingly, there is no assurance that the Company's expectations will be realized. The Company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.
Contact Information:
CONTACT:
Adam Friedman
Principal
Adam Friedman Associates
(917)-675-6250